For laboratory and research use only. Not for human or animal consumption. Sold to qualified researchers and licensed laboratories.
HomeShopLongevity & Skin › PT-141
PT-141 10 mg research peptide vial with lot PT1-2609-X label
Longevity & Skin · SKU P1-10

PT-141 10 mg

Melanocortin receptor agonist (bremelanotide) studied in neuroendocrine work.

$ 60 per 10 mg vial · free shipping over $300

In stock · ships same day on orders before 2pm ET

Purity (HPLC-UV)≥99.0% on lot PT1-2609-X
IdentityConfirmed by LC-MS
FormLyophilized powder, sealed vial
Endotoxin< 0.5 EU/mg (LAL)
Storage-20°C sealed · 2-8°C reconstituted
CAS number189691-06-3
Molecular formulaC50H68N14O10
Molecular weight1025.2 g/mol
Residues7
Volume pricing, applied automatically in the cart
QuantityPer unitYou save
3 to 4 units$55.807%
5 to 9 units$53.4011%
10+ units$50.4016%

Verify lot PT1-2609-X in the COA library · This month's lot report

Ships same day on orders before 2pm ET. For laboratory research use only. Not for human or animal consumption.

Frequently bought together

Supplies researchers add to this order

Reconstitution kit
Reconstitution kitKit · $49.99

What is PT-141?

PT-141, also called bremelanotide, is a cyclic heptapeptide analogue of alpha-MSH and a metabolite of melanotan-2. It acts at melanocortin receptors, principally MC3R and MC4R, and is studied for central rather than peripheral melanocortin signalling. Pepstral supplies it as a lyophilized powder for in-vitro laboratory research only.

What is PT-141 studied for?

  • MC3R and MC4R binding assays
  • Central melanocortin signalling research
  • Neuroendocrine pathway studies
  • Comparisons against melanotan-2

All applications above are in-vitro or preclinical research contexts. PT-141 is sold for laboratory research only and is not for human or animal use.

What does the certificate for lot PT1-2609-X show?

Every lot of PT-141 is tested by an independent US laboratory before it is listed. The report for lot PT1-2609-X is in the COA library and the lot number printed on the vial matches it. The current results:

TestMethodLot PT1-2609-X result
IdentityLC-MSMatches the calculated mass for the sequence
PurityHPLC-UV, 220 nm99.0%
Net peptide contentAmino acid analysisStated per vial on the certificate
EndotoxinLAL, chromogenic< 0.5 EU/mg
SterilityUSP <71>Pass

How is PT-141 handled and stored?

Sealed vials are stored at -20°C away from light and keep for 24 months. To reconstitute, add bacteriostatic water slowly down the inside wall of the vial and swirl until clear; never shake. Once in solution, keep at 2 to 8°C and use within the 28-day window on the certificate. The reconstitution guide covers volumes and syringe units and the concentration table gives the numbers for this vial.

Frequently asked questions

How does PT-141 relate to melanotan-2?

It is a metabolite of it, with the C-terminal amide replaced, which shifts activity away from MC1R and pigmentation.

Which receptors does it prefer?

It is described as acting principally at MC3R and MC4R rather than the MC1R pigmentary pathway.

Is PT-141 for human use?

No. Every product on this site is sold for in-vitro laboratory research only and is not for human or animal consumption, diagnostic or therapeutic use.

Related reading

Related

More in Longevity & Skin

GHK-Cu 50 mg research peptide vial

GHK-Cu

Longevity & Skin · 50 mg
≥99.8% purity · COA lot GK-2609-A
from$50
NAD+ 500 mg research peptide vial

NAD+

Longevity & Skin · 500 mg
≥99.3% purity · COA lot ND-2608-B
from$100
New
MOTS-c 10 mg research peptide vial

MOTS-c

Longevity & Skin · 10 mg
≥99.1% purity · COA lot MC-2609-E
from$100
Melanotan-1 10 mg research peptide vial

Melanotan-1

Longevity & Skin · 10 mg
≥99.0% purity · COA lot MEL-2609-X
from$55
COA on every lotPublished before listing
≥99% purityHPLC and LC-MS verified
Same-day shippingOrders before 2pm ET
Secure checkout256-bit encrypted
USA-basedSynthesized and shipped domestically
Discreet packagingPlain box, no product names

Restock alerts and new lot reports, by email

One email when a new certificate is published, when a sold-out compound is back, or when a new compound is added. About twice a month, nothing else.